UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1

CUSIP: 91307CAF9

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
326.89%
Total 13F principal
$2,603,000
Principal change
-$22,500,000
Total reported market value
$8,520,821
Number of holders
5
Value change
-$61,774,000
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 91307CAF9?
CUSIP 91307CAF9 identifies 91307CAF9 - UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q4 2015

As of 31 Dec 2015, UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 was held by 5 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $2,603,000 in principal (par value) of the bond. The largest 5 bondholders included CITIGROUP INC, PUTNAM INVESTMENTS LLC, Jefferies Group LLC, AGF INVESTMENTS INC., and Wellesley Investment Advisors. This page lists 5 institutional bondholders reporting positions for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.